Ranked [title] Word list | Historiographs | Help Glossary HistCite Guide About |
Nodes: 2913, Authors: 7350, Journals: 871, Outer References: 80285, Words: 5113
Yearly output | Document Type | Language | Institution | Institution with Subdivision | Country |
View: Overview | Sorted by LCS. |
# | Word | Pubs | TLCS | TGCS |
---|---|---|---|---|
1 | TUBERCULOSIS | 356 | 1569 | 5642 |
2 | EFFICACY | 68 | 1145 | 2528 |
3 | BCG | 153 | 1073 | 2705 |
4 | VACCINE | 108 | 860 | 1765 |
5 | PREVENTION | 86 | 772 | 1870 |
6 | LITERATURE | 30 | 712 | 2266 |
7 | PATIENTS | 176 | 711 | 6268 |
8 | PUBLISHED | 7 | 633 | 762 |
9 | HEALTH | 151 | 615 | 3621 |
10 | MYCOBACTERIUM | 159 | 567 | 2999 |
11 | METAANALYSIS | 23 | 557 | 2180 |
12 | MYOCARDIAL-INFARCTION | 53 | 526 | 3435 |
13 | COST-EFFECTIVENESS | 91 | 524 | 3602 |
14 | MEDICAL | 118 | 516 | 3018 |
15 | CLINICAL | 146 | 508 | 4442 |
16 | ACUTE | 89 | 489 | 4060 |
17 | VACCINATION | 129 | 474 | 1856 |
18 | METHODS | 39 | 452 | 2056 |
19 | TOMOGRAPHY | 36 | 415 | 855 |
20 | AIDS | 152 | 393 | 2155 |
21 | EVALUATION | 119 | 351 | 2017 |
22 | CARE | 80 | 333 | 1480 |
23 | CALMETTE-GUERIN | 62 | 327 | 1228 |
24 | ASSESSMENT | 62 | 323 | 1149 |
25 | COMPARISON | 44 | 320 | 1073 |
26 | EFFECT | 53 | 313 | 1293 |
27 | PREFERENCES | 25 | 311 | 1175 |
28 | VACCINES | 83 | 310 | 1207 |
29 | DIAGNOSTIC | 71 | 300 | 1802 |
30 | IMPLICATIONS | 47 | 300 | 1684 |
# | Word | Pubs | TLCS | TGCS |
31 | COMPUTED | 31 | 288 | 720 |
32 | OUTCOMES | 30 | 275 | 819 |
33 | IMMUNITY | 23 | 274 | 1033 |
34 | PROTECTIVE | 36 | 273 | 910 |
35 | PEPTIC-ULCER | 50 | 266 | 992 |
36 | BOVIS | 70 | 262 | 1445 |
37 | CHEST | 57 | 233 | 2103 |
38 | UNITED-STATES | 18 | 231 | 834 |
39 | HIV | 144 | 228 | 2233 |
40 | RISK | 102 | 224 | 1978 |
41 | ANALYSIS | 90 | 221 | 2174 |
42 | REVIEW | 54 | 216 | 3428 |
43 | UTILITIES | 22 | 215 | 1688 |
44 | TECHNOLOGY | 66 | 213 | 1699 |
45 | INFECTION | 98 | 210 | 1507 |
46 | ADMISSION | 19 | 205 | 502 |
47 | LOW | 17 | 204 | 334 |
48 | BACILLE | 38 | 201 | 705 |
49 | HUMAN | 55 | 200 | 1348 |
50 | TRENDS | 24 | 197 | 723 |
51 | PAIN | 60 | 195 | 2139 |
52 | BACILLUS-CALMETTE-GUERIN | 6 | 194 | 337 |
53 | EMERGENCY | 33 | 192 | 2046 |
54 | IMPACT | 71 | 190 | 1348 |
55 | PUBLIC-HEALTH | 14 | 189 | 390 |
56 | PREVENT | 8 | 186 | 387 |
57 | ALTERNATIVES | 5 | 179 | 217 |
58 | NEW | 93 | 178 | 1718 |
59 | COST | 49 | 177 | 1181 |
60 | EDUCATION | 20 | 177 | 423 |
# | Word | Pubs | TLCS | TGCS |
61 | PROSPECTS | 10 | 172 | 327 |
62 | CORONARY-CARE-UNIT | 6 | 171 | 171 |
63 | PROBABILITY | 5 | 169 | 179 |
64 | RESPONSES | 45 | 168 | 757 |
65 | MEASUREMENT | 19 | 167 | 1409 |
66 | CIMETIDINE | 18 | 165 | 334 |
67 | SCREENING | 48 | 165 | 888 |
68 | BACILLUS | 37 | 164 | 763 |
69 | REPORT | 23 | 163 | 894 |
70 | BODY | 15 | 162 | 300 |
71 | OBSTACLES | 1 | 162 | 162 |
72 | CASE | 30 | 158 | 604 |
73 | PROTECTION | 31 | 157 | 570 |
74 | TIME | 39 | 157 | 985 |
75 | TREATMENT | 97 | 155 | 1810 |
76 | XENOTRANSPLANTATION | 65 | 155 | 494 |
77 | INTRODUCTION | 19 | 153 | 663 |
78 | DISEASE | 112 | 152 | 2235 |
79 | STRATEGIES | 40 | 150 | 978 |
80 | THERAPEUTIC | 19 | 150 | 434 |
81 | USE | 100 | 150 | 2382 |
82 | RUBELLA | 23 | 149 | 565 |
83 | MODEL | 37 | 148 | 625 |
84 | COSTS | 26 | 147 | 663 |
85 | INFANTS | 13 | 147 | 203 |
86 | SURGICAL-TREATMENT | 9 | 147 | 333 |
87 | TECHNOLOGY-ASSESSMENT | 24 | 146 | 306 |
88 | DNA | 25 | 145 | 650 |
89 | VALUE | 31 | 140 | 549 |
90 | EXPRESSING | 14 | 139 | 530 |
# | Word | Pubs | TLCS | TGCS |
91 | PREMARITAL | 20 | 138 | 199 |
92 | COMPUTERIZED | 10 | 137 | 218 |
93 | VARIATION | 10 | 137 | 586 |
94 | CRANIAL | 6 | 134 | 172 |
95 | BENEFIT | 6 | 133 | 382 |
96 | METAANALYSES | 1 | 132 | 132 |
97 | NEWBORNS | 3 | 132 | 141 |
98 | RECOMBINANT | 33 | 132 | 575 |
99 | UNIT | 27 | 131 | 713 |
100 | UNCERTAINTY | 9 | 130 | 262 |
101 | ECONOMIC | 30 | 129 | 2009 |
102 | PLANS | 2 | 129 | 147 |
103 | INDIVIDUAL | 14 | 125 | 322 |
104 | PLANNING | 32 | 125 | 457 |
105 | SCANNING | 18 | 122 | 280 |
106 | HUMAN-IMMUNODEFICIENCY-VIRUS | 18 | 121 | 356 |
107 | THERAPY | 52 | 121 | 1809 |
108 | USING | 49 | 121 | 1763 |
109 | ANTIGEN | 31 | 119 | 616 |
110 | COLLECTIVE | 2 | 118 | 118 |
111 | CONSIDERATIONS | 15 | 118 | 205 |
112 | IMMUNE | 43 | 118 | 761 |
113 | PRACTICES | 18 | 118 | 819 |
114 | RESEARCH | 67 | 117 | 3429 |
115 | STATE | 22 | 115 | 1367 |
116 | UTILITY | 47 | 115 | 658 |
117 | CONTROL | 52 | 112 | 741 |
118 | PERTUSSIS | 31 | 112 | 410 |
119 | RADIATION-THERAPY | 14 | 111 | 255 |
120 | RELATIONSHIP | 13 | 107 | 417 |
# | Word | Pubs | TLCS | TGCS |
121 | HETEROLOGOUS | 2 | 106 | 308 |
122 | TESTING | 68 | 106 | 1624 |
123 | SUMMARY | 9 | 104 | 330 |
124 | META-ANALYSES | 4 | 103 | 880 |
125 | IMAGING | 52 | 101 | 699 |
126 | TRIAL | 39 | 100 | 1813 |
127 | COMPULSORY | 8 | 98 | 100 |
128 | CELLS | 33 | 96 | 676 |
129 | QUALITY-OF-LIFE | 17 | 96 | 904 |
130 | RESULTS | 43 | 96 | 1451 |
131 | QUALITY | 51 | 95 | 1093 |
132 | HIGH | 12 | 94 | 233 |
133 | PROTEIN | 30 | 94 | 405 |
134 | RANDOMIZED | 27 | 94 | 2539 |
135 | TECHNICAL | 3 | 94 | 95 |
136 | DOCTORS | 8 | 93 | 151 |
137 | FINDINGS | 9 | 93 | 312 |
138 | TESTS | 29 | 93 | 503 |
139 | MEASURING | 20 | 92 | 633 |
140 | COMPUTED-TOMOGRAPHY | 45 | 91 | 762 |
141 | LIFE | 34 | 90 | 1280 |
142 | NUMBERS | 3 | 88 | 115 |
143 | COMPUTER | 6 | 87 | 413 |
144 | EXPRESSION | 15 | 84 | 393 |
145 | MULTICENTER | 9 | 84 | 974 |
146 | STRAINS | 9 | 84 | 442 |
147 | APPRAISAL | 2 | 83 | 861 |
148 | CONTROLLED | 20 | 83 | 2030 |
149 | SECRETED | 10 | 83 | 435 |
150 | BEHAVIOR | 23 | 82 | 1066 |
# | Word | Pubs | TLCS | TGCS |
151 | INFLUENCE | 22 | 82 | 511 |
152 | MOLECULAR | 12 | 82 | 585 |
153 | CORONARY | 21 | 81 | 440 |
154 | CULTURES | 10 | 81 | 191 |
155 | GUIDELINES | 25 | 81 | 1816 |
156 | MYCOBACTERIA | 13 | 81 | 250 |
157 | STOOL | 13 | 81 | 175 |
158 | ADVERSE | 16 | 80 | 216 |
159 | DIFFERENTIAL | 16 | 80 | 434 |
160 | PHYSICIANS | 37 | 80 | 1641 |
161 | CELL | 33 | 79 | 636 |
162 | IMMUNOGENICITY | 15 | 77 | 312 |
163 | VARIABILITY | 3 | 77 | 202 |
164 | ASSESS | 4 | 76 | 197 |
165 | CONSEQUENT | 1 | 74 | 136 |
166 | HOSPITAL | 38 | 74 | 899 |
167 | WELL-BEING | 1 | 74 | 136 |
168 | CLINICAL-TRIALS | 11 | 73 | 656 |
169 | PROGRESS | 16 | 73 | 541 |
170 | ROOM | 8 | 73 | 977 |
171 | EVENTS | 11 | 72 | 155 |
172 | CHILDREN | 52 | 71 | 686 |
173 | IMMUNIZATION | 34 | 71 | 552 |
174 | LOW-COST | 3 | 71 | 71 |
175 | MEDICINE | 39 | 71 | 1161 |
176 | RISKS | 17 | 71 | 498 |
177 | TEST | 37 | 71 | 706 |
178 | PROTEINS | 16 | 70 | 380 |
179 | VIRUS | 30 | 70 | 543 |
180 | CHALLENGE | 16 | 69 | 313 |
# | Word | Pubs | TLCS | TGCS |
181 | HEALTH-CARE | 40 | 69 | 922 |
182 | HEALTH-STATE | 7 | 69 | 441 |
183 | INSTITUTE-OF-MEDICINE | 2 | 69 | 105 |
184 | MICE | 30 | 69 | 392 |
185 | MYCOBACTERIAL | 31 | 69 | 442 |
186 | PREVENTING | 10 | 69 | 217 |
187 | PROSPECTIVE-STUDY | 7 | 69 | 112 |
188 | YEARS | 20 | 69 | 398 |
189 | FOLLOWING | 11 | 68 | 125 |
190 | INFECTIONS | 17 | 68 | 415 |
191 | T-CELL | 8 | 68 | 428 |
192 | CHRONIC | 18 | 67 | 480 |
193 | GLOBAL | 24 | 67 | 253 |
194 | META-ANALYSIS | 38 | 67 | 1531 |
195 | THROMBOLYSIS | 6 | 67 | 377 |
196 | TRIALS | 36 | 66 | 2417 |
197 | CARDIAC | 30 | 65 | 1399 |
198 | DIFFERENT | 9 | 65 | 237 |
199 | PROTOCOL | 7 | 65 | 587 |
200 | DECISION | 35 | 64 | 331 |
Page 1 of 26: [ 1 2 3 4 5 6 7 8 9 10 ] 11 21